Simple jQuery Dropdowns

Browsing by Author Saengsuree Jootar

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 29  next >
Issue DateTitleAuthor(s)
1-Apr-2004Allogeneic Peripheral Blood Stem Cell Transplantation in Children with Homozygous β-Thalassemia and Severe β-Thalassemia/Hemoglobin E DiseaseSamart Pakakasama; Suradej Hongeng; Wattana Chaisiripoomkere; Ampaiwan Chuansumrit; Nongnuch Sirachainun; Saengsuree Jootar; Mahidol University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University
1-Jul-2011Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodiesKearkiat Praditpornsilpa; Khajohn Tiranathanagul; Pawinee Kupatawintu; Saengsuree Jootar; Tanin Intragumtornchai; Kriang Tungsanga; Tanyarat Teerapornlertratt; Dusit Lumlertkul; Natavudh Townamchai; Paweena Susantitaphong; Pisut Katavetin; Talerngsak Kanjanabuch; Yingyos Avihingsanon; Somchai Eiam-Ong; Chulalongkorn University; Thai Red Cross Agency; Mahidol University; Chiang Mai University
1-Dec-2006Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansionSaengsuree Jootar; Nida Pornprasertsud; Sawang Petvises; Busaba Rerkamnuaychoke; Sinee Disthabanchong; Samart Pakakasama; Artit Ungkanont; Suradej Hongeng; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Mahidol University; Thammasat University
1-Apr-2012CML treatment in Asia-Pacific regionSaengsuree Jootar; Mahidol University
1-Jul-2018Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinibSung Eun Lee; Soo Young Choi; Soo Hyun Kim; Saengsuree Jootar; Hyeoung Joon Kim; Sang Kyun Sohn; Joon Seong Park; Sung Hyun Kim; Dae Young Zang; Suk Joong Oh; Dong Wook Kim; Ajou University, School of Medicine; Kyungpook National University Hospital; Chonnam National University, College of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Dong-A University, College of Medicine; Samsung Group; Hallym University, College of Medicine; The Catholic University of Korea
1-Apr-2014Cost-utility analysis of dasatinib and nilotinib in patients with chronic myeloid leukemia refractory to first-line treatment with imatinib in ThailandWantanee Kulpeng; Sumalai Sompitak; Saengsuree Jootar; Kanchana Chansung; Yot Teerawattananon; Thailand Ministry of Public Health; Mahidol University; Khon Kaen University
15-Sep-2009Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: Two-year follow-up of a randomized phase 2 study (START-R)Hagop Kantarjian; Ricardo Pasquini; Vincent Lévy; Saengsuree Jootar; Jerzy Holowiecki; Nelson Hamerschlak; Timothy Hughes; Eric Bleickardt; David Dejardin; Jorge Cortes; Neil P. Shah; University of Texas MD Anderson Cancer Center; Hospital de Clínicas de Curitiba; Hopital Saint-Louis; Mahidol University; University Hospital-SPSKM; Hospital Israelita Albert Einstein; Institute of Medical and Veterinary Science Australia; Bristol-Myers Squibb; UCSF School of Medicine
1-Jan-2012Depletion of alloreactive T cells for tolerance induction in a recipient of kidney and hematopoietic stem cell transplantationsKanchana Tangnararatchakit; Wiwat Tirapanich; Usanarat Anurathapan; Wiwat Tapaneya-Olarn; Samart Pakakasama; Saengsuree Jootar; Shimon Slavin; Suradej Hongeng; Mahidol University; International Center for Cell Therapy and Cancer Immunotherapy (CTCI)
21-Jan-2011DNA detection of chronic myelogenous leukemia by magnetic nanoparticlesKulachart Jangpatarapongsa; Duangporn Polpanich; Vichanan Yamkamon; Yuranun Dittharot; Jutharat Peng-On; Raweewan Thiramanas; Suradej Hongeng; Saengsuree Jootar; Lalida Charoenmak; Pramuan Tangboriboonrat; Mahidol University; Thailand National Nanotechnology Center; Faculty of Medicine, Ramathibodi Hospital, Mahidol University
1-Jul-2014Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitorsSung Hyun Kim; Hari Menon; Saengsuree Jootar; Tapan Saikia; Jae Yong Kwak; Sang Kyun Sohn; Joon Seong Park; Seong Hyun Jeong; Hyeoung Joon Kim; Yeo Kyeoung Kim; Suk Joong Oh; Hawk Kim; Dae Young Zang; Joo Seop Chung; Ho Jin Shin; Young Rok Do; Jeong A. Kim; Dae Young Kim; Chul Won Choi; Sahee Park; Hye Lin Park; Gong Yeal Lee; Dae Jin Cho; Jae Soo Shin; Dong Wook Kim; Dong-A University; Tata Memorial Hospital; Mahidol University; Prince Aly Khan Hospital; Chonbuk National University, School of Medicine; Kyungpook National University Hospital; Ajou University; Chonnam National University; SungKyunKwan University, School of Medicine; University of Ulsan, College of Medicine; Hallym University; Pusan National University, College of Medicine; Keimyung University, Dongsan Medical Center; The Catholic University of Korea; Korea University; IL-YANG Pharmaceutical Co., Ltd.
1-May-2012Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisisFranck E. Nicolini; Tamas Masszi; Zhixiang Shen; Neil J. Gallagher; Saengsuree Jootar; Bayard L. Powell; Pedro Enrique Dorlhiac-Llacer; Ming Zheng; Tomasz Szczudlo; Anna Turkina; Hopital Edouard Herriot; Szent Laszlo Hospital; Ruijin Hospital; Novartis International AG; Mahidol University; Wake Forest University; Universidade de Sao Paulo - USP; Novartis Pharmaceuticals Corporation; National Research Center for Hematology
1-Jan-2012Expanding Nilotinib Access in Clinical Trials (ENACT): An open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phaseFranck E. Nicolini; Anna Turkina; Zhi Xiang Shen; Neil Gallagher; Saengsuree Jootar; Bayard L. Powell; Carmino De Souza; Ming Zheng; Tomasz Szczudlo; Philipp Le Coutre; Hopital Edouard Herriot; National Research Center for Hematology; Ruijin Hospital; Novartis International AG; Mahidol University; Wake Forest University Baptist Medical Center; Universidade Estadual de Campinas; Novartis Pharmaceuticals Corporation; Charité – Universitätsmedizin Berlin
1-Dec-2000Full chimerism effect of nonmyeloablative haploidentical stem cell transplantation in pediatric resistant acute myeloid leukemia patients: An evidence of graft versus leukemiaSuradej Hongeng; Artit Ungkanont; Pimpun Tardtong; Busaba Rerkamnuaychoke; Saengsuree Jootar; Phongjan Hathirat; Mahidol University
1-Sep-1997Levels of Serum Tumor Necrosis Factor Alpha in Relation to Clinical Involvement and Treatment among Thai Adults with Plasmodium falciparum MalariaSuporn Chuncharunee; Saengsuree Jootar; Apichai Leelasiri; Napaporn Archararit; Wichai Prayoonwiwat; Wichian Mongkonsritragoon; Pianvit Polvicha; Tanomsri Srichaikul; Mahidol University; Pramongkutklao Hospital
1-Sep-2009Long-term outcomes of de novo acute myeloid leukemia in Thai patientsPimjai Niparuck; Suporn Chuncharunee; Artit Ungkanont; Umaporn Udomtrupayakul; Puntep Aungchaisuksiri; Budsaba Rerkamnuatchoke; Saengsuree Jootar; Vichai Atichartakarn; Mahidol University
1-Sep-2016Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous LeukemiaYanaphat Manthawornsiri; Duangporn Polpanich; Vichanan Yamkamon; Raweewan Thiramanas; Suradej Hongeng; Budsaba Rerkamnuaychoke; Saengsuree Jootar; Pramuan Tangboriboonrat; Kulachart Jangpatarapongsa; Mahidol University; Thailand National Nanotechnology Center
1-Jun-1996Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: An update of the first series in ThailandSaengsuree Jootar; Artit Ungkanont; Suporn Chuncharunee; Vichai Atichartakarn; Mahidol University
1-May-1998Myelodysplastic syndromes in Thailand: A retrospective pathologic and clinical analysis of 117 casesTanin Intragumtornchai; Wichai Prayoonwiwat; Daratana Swasdikul; Nipha Suwanwela; Boonsom Chaimongkol; Saengsuree Jootar; Kanchana Chansung; Suporn Chancharunee; Apichai Leelasiri; Yataro Yoshida; Chulalongkorn University; Pramongkutklao Hospital; Rajvidhi Hospital; Chiang Mai University; Mahidol University; Srinagarind hospital; Kyoto University
1-Dec-2017Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemiaJae Yong Kwak; Sung Hyun Kim; Suk Joong Oh; Dae Young Zang; Hawk Kim; Jeong A. Kim; Young Rok Do; Hyeoung Joon Kim; Joon Seong Park; Chul Won Choi; Won Sik Lee; Yeung Chul Mun; Jee Hyun Kong; Joo Seop Chung; Ho Jin Shin; Dae Young Kim; Jinny Park; Chul Won Jung; Udomsak Bunworasate; Narcisa Sonia Comia; Saengsuree Jootar; Arry Harryanto Reksodiputro; Priscilla B. Caguioa; Sung Eun Lee; Dong Wook Kim; Chonbuk National University, School of Medicine; Dong-A University; SungKyunKwan University, School of Medicine; Hallym University; University of Ulsan, College of Medicine; The Catholic University of Korea; Keimyung University, Dongsan Medical Center; Chonnam National University; Ajou University; Korea University; Inje University Paik Hospital; Ewha Womans University School of Medicine; Wonju Severance Christian Hospital; Pusan National University, College of Medicine; Gachon University; Chulalongkorn University; Mary Mediatrix Medical Center; Mahidol University; University of Indonesia, RSUPN Dr. Cipto Mangunkusumo; St. Luke's Medical Center Quezon City
1-May-2005POEMS syndrome with venous sinus thrombosis and visual failure: A case reportRawiphan Witoonpanich; Sriphan Phankhian; Saengsuree Jootar; Anuchit Poonyathalang; Surapon Worapongpaiboon; Suchart Phudhichareonrat; Niramol Chanplakorn; Mahidol University